Company Overview and News

1
BlissCo Cannabis Corp Explains to Uptick Newswire’s Stock Day Podcast How They are Taking on the Cannabis Market

2018-10-09 globenewswire - 1
PHOENIX, Oct. 09, 2018 (GLOBE NEWSWIRE) -- BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) (“BlissCo” or “Company”) is a licensed producer and future distributor of ultra-premium cannabis. Damian Kettlewell, CEO, Founder and Chair spoke with Stock Day’s Everett Jolly about the cannabis market in Canada and the company’s recent news
NXTTF

 
Namaste Technologies: Possibly Building The Amazon Of Bagholders

2018-10-02 seekingalpha
The company has launched two incredibly myopic and questionable policies this year to support its stock price.
NXTTF

 
RMMI Corp. Announces Supply Agreement With Namaste Technologies Inc.

2018-09-26 globenewswire
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.
NXTTF

 
Namaste Enters Into $45 Million Bought Deal Equity Financing

2018-09-26 globenewswire
VANCOUVER, British Columbia, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (TSXV:N) (Frankfurt: M5BQ) (OTCMKTS: NXTTF) (“Namaste” or the “Company”), is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital has agreed to purchase, as co-lead underwriter and joint bookrunner with Canaccord Genuity Corp., 15,000,000 units of the Company (the “Units”), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $3.
NXTTF

35
Cannabis stocks surge, fueled by earnings, investments and bullish analyst comments

2018-09-25 marketwatch - 4
Aurora Cannabis swings to profit, Aleafia Health gets a $10 million investment and Benchmark is bullish on Canopy Growth
STZ.B ALEAF NXTTF ACBFF CRON STZ NBEV CGC TLRY ABRW ACB DTEA WEED

24
Shares in pot stocks Tilray, New Age Beverages extend selloff; Alefia Health shares soar again

2018-09-24 marketwatch
Shares of New Age Beverages Corp. tumbled on heavy volume, as they extended their pullback from record highs, while Tilray Inc.’s headed for a third straight selloff, as investors continued to adjust their cannabis positions ahead of Canada’s full-legalization next month.
ABRW ACB ALEAF NXTTF DTEA WEED ACBFF CRON NBEV CGC TLRY

 
Namaste Technologies granted first ever "sales only" ACMPR license by Health Canada

2018-09-24 proactiveinvestors.com.au
Namaste Technologies (CVE:N OTCMKTS:NXTTF) President and CEO Sean Dollinger dropped in to the Vancouver Studios of Proactive Investors to talk about his companies new Access to Cannabis for Medical Purpose Regulations "sales only" license from Health Canada. This is the first of it's kind ever granted by the governing medical authority in Canada.
NXTTF

 
Namaste Technologies granted first ever "sales only" ACMPR licence by Health Canada

2018-09-21 proactiveinvestors.com.au
Namaste Technologies (CVE:N OTCMKTS:NXTTF) President and CEO Sean Dollinger dropped in to the Vancouver Studios of Proactive Investors to talk about his companies new Access to Cannabis for Medical Purpose Regulations "sales only" license from Health Canada. This is the first of it's kind ever granted by the governing medical authority in Canada.
NXTTF

 
BlissCo Signs Agreement to Offer Same-day Delivery of Medical Cannabis

2018-09-13 globenewswire
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B), (“BlissCo”) or the (“Company”) is pleased to announce that it has entered into an agreement with Pineapple Express Delivery Inc. The agreement will enable BlissCo to offer same-day delivery of medical cannabis to its patients.
NXTTF PNPL

 
Namaste Technologies, Inc., VP Kory Zelickson Joins Uptick Newswire’s ‘Stock Day’ Podcast With Everett Jolly

2018-09-04 globenewswire
PHOENIX, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies, Inc. (OTC:NXTTF) (the “Company”), Vice President of Business Development Kory Zelickson is discussing his company’s explosive growth on the latest “Stock Day” podcast with Uptick Newswire’s Everett Jolly.
NXTTF

29
Namaste Technologies Could Be the Amazon of Pot

2018-08-09 investorplace - 7
It is common practice to build a business based on the past success of a similar model. It’s also smart. For example, Chinese technology giant Baidu (NASDAQ:BIDU) is often dubbed the “Google of China.” Over the last decade, BIDU is a 20-bagger that is now worth $90 billion. Another example is Iqiyi (NASDAQ:IQ), or the “Netflix of China.” Since its IPO, the stock is up over 100% in four months.
NXTTF IQ BIDU

 
BlissCo Hires Experienced Clinic Leader to Drive Revenue with Patient Care and Call Center Programs

2018-08-09 globenewswire
VANCOUVER, British Columbia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B), (“BlissCo”) or the (“Company”) is pleased to announce that the company has added Shannon Khan to its team to serve as Patient Care and Call Center Lead.
NXTTF

26
Daily CryptoCann™ Report: Riot Blockchain to develop private Bitcoin mining pool; Province Brands creates first beer brewed from cannabis

2018-07-26 proactiveinvestors.com.au
Alphabet Inc’s (NASDAQ:GOOG) cloud service is teaming up with former JPMorgan & Chase Co (NYSE:JPM) executive Blythe Masters’ startup, providing the necessary tools to make creating blockchain applications easier for developers, according to a CoinDesk report.
RIOT NXTTF JPM GOOGL CCF GOOG BIOP TLRY

21
Canada Goes Green: Here Are Your Legal Marijuana Options

2018-06-21 investorplace - 1
Not to be outdone by our own initiatives regarding legal marijuana, Canada stepped up as the first G7 nation to approve recreational weed. Our northern neighbor’s upper chamber voted 52 to 29 favoring Bill C-45, a proposal to overturn a multi-year cannabis ban.
TWMJF ACB NXTTF WEED ACBFF CGC

4
Digital Utilities Ventures, Inc. Engages PCAOB Auditing Firm

2018-06-04 accesswire
BOSTON, MA / ACCESSWIRE / June 4, 2018 / Digital Utilities Ventures, Inc. (OTC PINK: DUTV), an emerging seed to sale player in the growing legal cannabis marketplace, today announces it has entered into an auditing agreement with PCAOB accounting firm Boyle CPA, LLC Certified Public Accountants 361 Hopedale Drive SE P Bayville, NJ 08721Boyle CPA, LLC. Digital will be filing full audited financial for the fiscal year ending May 31, 2018.
NXTTF DUTV CANN

NXTTF: Namaste Technologies Inc (CNSX:N) Analysis and Research Report

2018-02-04 - Asif

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience. Description of the business Dollinger E...

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 62987D108